Css LLC Axsome Therapeutics, Inc. Put Options Transaction History

Css LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $1.08 Million - $2.16 Million	27,100 Added 271.0%	37,100 $2.86 Million
Q3 2022 Nov 14, 2022	SELL	$36.06 - $69.85 $717,594 - $1.39 Million	-19,900 Reduced 66.56%	10,000 $446,000
Q2 2022 Aug 15, 2022	BUY	$21.74 - $46.75 $73,916 - $158,950	3,400 Added 12.83%	29,900 $1.15 Million
Q4 2021 Feb 14, 2022	BUY	$30.7 - $43.36 $73,680 - $104,064	2,400 Added 9.96%	26,500 $1 Million
Q3 2021 Nov 15, 2021	BUY	$19.91 - $68.26 $469,876 - $1.61 Million	23,600 Added 4720.0%	24,100 $795,000
Q3 2020 Nov 16, 2020	SELL	$68.34 - $85.84 $1.95 Million - $2.45 Million	-28,500 Reduced 98.28%	500 $36,000
Q2 2020 Aug 14, 2020	BUY	$49.87 - $98.69 $1.43 Million - $2.83 Million	28,700 Added 9566.67%	29,000 $2.39 Million
Q1 2020 May 15, 2020	SELL	$41.2 - $101.31 $5.48 Million - $13.5 Million	-133,100 Reduced 99.78%	300 $18,000
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $2.23 Million - $14.2 Million	133,400 New	133,400 $13.8 Million

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.